Intarcia Therapeutics Sucks Customer Reviews and Feedback
Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. In 2013, Intarcia relocated its headquarters to Boston, keeping its manufacturing facility in Hayward, CA. In addition to Boston and Hayward, Intarcia also has a location in Research Triangle Park, North Carolina, where it discovers and develops peptides for its drug delivery system.
In 2005, the executive leadership of Intarcia was largely vested in two people, Karling Leung and James Ahlers, President/CEO/Director and Vice President/CFO/Finance & Operations Officer, respectively. By 2012, Kurt Graves had replaced Karling Leung as President and CEO. Kurt Graves has been with Intarcia since August 2010, first serving as Executive Chairman before becoming President and CEO in April 2012. As of 2016, Intarcia is engaged in development of a "potential once-a-year type 2 diabetes treatment". Referred to as ITCA 650, the therapeutic consists of exenatide delivered via its Medici Drug Delivery System, "a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides".
A customer from Canada left this anonymous review, "The product wasn't unique and there was a lot of learning to do for a drug-device combination product. However, the overall company strategic goals were poorly defined and management was not aligned on the overall objectives. Poor communication from management and not enough trust of their employees."
Former Employee - Process Technician III says"The toxic environment from working with the swing shift and the politics. Two of the managers were married and they were working together collectively to manipulate the team."
Former Employee - Manager says"Upper Management did not have appropriate skills or oversight. HUGE money waste, trying to act like a big pharma company with 250 FTEs and 300 consultants."
Former Employee - Manufacturing Associate says"Intarcia is one big con . The FDA keeps saying no and No to them despite all the contractors that they hire for five months or less to figure out what the permanent employees trashed . Poor regulatory staff and even more dismal QA . Sadly the failed employees have scattered to other companies and are doing their so called magic there . I wouldn’t third any of these leaders ."
Former Employee - Anonymous Employee says"Management in Hayward terrible. Ok place to work during the day if you’r there to work no politics. Later shift you will be facing some toxics that’s running the show with no clue. That are not there to work just drama."
Former Employee - Engineer says"Promotion based on whom you know, not what you were responsible for. Poor roles and responsibilities. QA actions and decisions were based on fear not science. Trust consultants and not employees. Leadership in both engineering and manufacturug are terrible."
Former Employee - Manufacturing Technician says"No one there knows what they are doing ...a struggle to pass FDA"
Former Employee - Director says"The management is inferior at preparing the business for success. Many leaders are just out of their depth and rely 100% on consultants. Many leaders have outdated information as their basis for decisions. Most leaders in manufacturing have never worked in an aseptic environment, never brought a biotech DP or a medical device to market. Everything internally is clinical and R&D scale, but they have spent $1.5Bn on development."
Former Employee - Anonymous Employee says"Mismanagement - both in resources/times lines and management. Leaders are unable to make decisions and are more worried about how they are perceived by CEO and each other than getting the work done. Everyone questions whether they're qualified to lead. Talk about each other, creating lots of tension. Time lines are unrealistic. Multiple rounds of layoffs. Lack of transparency - everyone is being told different things, employees in different sites and groups have different updates, what's said publicly doesn't match what we're hearing, everyone is left trying to figure out what's true because of an overworked rumor mill. No culture or values - lots of values written on the walls but they don't mean anything, no one follows them, culture is depressing and leaders just tell employees they have to fix it but they're not doing anything to help. Employees aren't valued either and there is no clear direction for work, so it is hard to feel challenged or useful."
Former Employee - Anonymous Employee says"Management focused on personal goals and individual success instead of team and company success, therefore, creating a toxic environment."
Former Employee - Anonymous Employee says"Cronyism. Culture-destroying employees go unchecked for too long."
Contractor (Former Employee) says"Stay away from Intarcia - management is delusional and out of touch with the rank-and-file. Contractors are treated horribly, no desks or dedicated workspaces so you will be thrown into any available room with 10-12 other contractors. Avoid this company as it will likely fail!"
Document Associate (Current Employee) says"Was told this was a six-month to permanent role, I left my current situation with the promise the role would convert to a permanent role after that time. A few weeks later, was informed by a manager that the job was only going on for a few more weeks. The old bait & switch. I was perfectly fine and secure in the job I left to take this assignment.Counter commute, not much traffic battleNo one knows what’s going on in this business. NO ONE."
Management (Current Employee) says"There is a lack of communication from middle management to individual contributors. There’s always a sense of urgency with very unclear direction. Instead of each department working together to accomplish a task or project each department operates as a fiefdom in which collaboration across the hall for the better good doesn’t occur as much as it should in a startup environment. Only way to get your way is through politics of who has the shorter line to the VP - unfortunately. Lots of favoritism - especially favoritism of the unskilled. There’s no real transparency from the director level and below. The lower you go the murkier it gets. There are some people with a very good and collaborative mindset but they’re very few and far between. Not the best environment for starters. And definitely not a good environment for the quiet talented individuals. Base salary provided you are exempt and negotiated well.Middle management - lack of leadership, communication, & direction"
Sr. Manager (Former Employee) says"The product was unique and there was a lot of learning to do for a drug-device combination product. However, the overall company strategic goals were poorly defined and management was not aligned on the overall objectives. Poor communication from management and not enough trust of their employees."
Senior Buyer Intarcia Therapeutics (Current Employee) says"Overall, it's a good company. Wish they had more room for growth, but at the moment they do not. Once they go commercial they my open up more jobs. They're struggling getting the drug approved by the FDA."
Manager (Current Employee) says"The company is in the right direction in the hopes of helping millions of people with Type II diabetes. The revolutionary device and drug combination will nullify the adherence issue."
Accounting Intern (Former Employee) says"Great product and great company vision. However, management seemed weak and distant from employees. No motivation to do your job other than the fact that you have to do your job. I did not learn much but I picked up a few important skills in MS Excel and SAP. Company seemed very disorganized and was not an inviting nor exciting atmosphere to work for."
cofoundertron says"Like Intarcia Therapeutics, but for civics"
cofoundertron says"Like Intarcia Therapeutics, but for veterans"
cofoundertron says"Like Intarcia Therapeutics, but for talk radio"
DiabetesTweets says"What's So Trendy about Non-insulin Therapies for Diabetes Market That Everyone Went Crazy over It? | GSK, Eli Lilly… https://t.co/JKwmHe5D5E"
In The News
FierceBiotech reports"Months after FDA rejection, Intarcia cuts 60 jobs and halts 2 late-stage trials"
Boston Business Journal reports"FDA warned Intarcia about manufacturing issues before drug rejection"
Endpoints News reports"Slammed by a trial hold, Intarcia terminates studies and axes staff in wake of an FDA rejection"
Boston Business Journal reports"Intarcia's diabetes drug-and-device once again rejected by FDA"